Johnson & Johnson Price to Sales Ratio 2006-2019 | JNJ

Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of June 24, 2019 is .
Johnson & Johnson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-06-24 143.06 4.77
2019-03-31 139.79 $30.01 4.66
2018-12-31 128.20 $29.91 4.29
2018-09-30 136.39 $29.79 4.58
2018-06-30 118.99 $29.51 4.03
2018-03-31 124.74 $28.73 4.34
2017-12-31 135.14 $27.86 4.85
2017-09-30 124.99 $26.99 4.63
2017-06-30 126.38 $26.21 4.82
2017-03-31 118.20 $25.95 4.55
2016-12-31 108.63 $25.74 4.22
2016-09-30 110.62 $25.58 4.32
2016-06-30 112.83 $25.27 4.46
2016-03-31 99.94 $24.98 4.00
2015-12-31 94.20 $24.90 3.78
2015-09-30 84.98 $24.94 3.41
2015-06-30 88.03 $25.29 3.48
2015-03-31 90.21 $25.75 3.50
2014-12-31 93.12 $25.91 3.59
2014-09-30 94.31 $25.91 3.64
2014-06-30 91.94 $25.56 3.60
2014-03-31 85.73 $24.96 3.43
2013-12-31 79.36 $24.78 3.20
2013-09-30 74.60 $24.65 3.03
2013-06-30 73.34 $24.60 2.98
2013-03-31 69.12 $24.30 2.84
2012-12-31 58.96 $24.00 2.46
2012-09-30 57.45 $23.61 2.43
2012-06-30 55.82 $23.32 2.39
2012-03-31 53.98 $23.40 2.31
2011-12-31 53.20 $23.42 2.27
2011-09-30 51.19 $23.17 2.21
2011-06-30 52.99 $22.79 2.33
2011-03-31 46.79 $22.30 2.10
2010-12-31 48.41 $22.06 2.19
2010-09-30 48.08 $22.38 2.15
2010-06-30 45.40 $22.40 2.03
2010-03-31 49.67 $22.40 2.22
2009-12-31 48.69 $22.20 2.19
2009-09-30 45.67 $21.62 2.11
2009-06-30 42.26 $21.84 1.94
2009-03-31 38.79 $22.15 1.75
2008-12-31 43.76 $22.41 1.95
2008-09-30 50.27 $22.54 2.23
2008-06-30 46.39 $22.05 2.10
2008-03-31 46.44 $21.45 2.17
2007-12-31 47.44 $20.94 2.27
2007-09-30 46.44 $20.08 2.31
2007-06-30 43.27 $19.45 2.22
2007-03-31 42.04 $18.76 2.24
2006-12-31 45.79 $17.96 2.55
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $377.257B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $242.802B 14.18
Merck (MRK) United States $217.738B 18.75
Novartis AG (NVS) Switzerland $213.652B 18.46
Novo Nordisk (NVO) Denmark $124.229B 20.67
AbbVie (ABBV) United States $116.463B 9.63
Eli Lilly (LLY) United States $112.121B 20.81
Sanofi (SNY) France $110.213B 13.59
AstraZeneca (AZN) United Kingdom $104.761B 12.06
GlaxoSmithKline (GSK) United Kingdom $99.894B 12.66
Bristol-Myers Squibb (BMY) United States $80.706B 11.92